These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Antitumor activity of howiinol (GHM-10) on L1210 cells in vitro].
    Author: He J, Ye Y, Xu C.
    Journal: Yao Xue Xue Bao; 1998 Aug; 33(8):566-70. PubMed ID: 12016894.
    Abstract:
    Howiinol(GHM-10) is a new compound isolated from Goniothalamus howii. Previous studies showed that GHM-10 significantly inhibited the growth of cancer cells both in vitro and in vivo. In the present study, the characteristics of the inhibitory effect of GHM-10 on L1210 cells was investigated. The results showed that the IC50 of L1210 cells treated with GHM-10 for 1 h, 24 h, and 7 d was 6.85, 3.32 and 1.59 micrograms.ml-1, respectively. This outcome is in compliance with the hypothesis that GHM-10 is a cell cycle non-specific cytotoxic drug. When L1210 cells were treated with 1-2 micrograms.ml-1 of GHM-10 for 24 h, the growth rate and mitotic index were decreased and the morphology of cell nuclei changed, but the cell viability remained at the level of 96% or more, indicating that GHM-10 mainly inhibited cell proliferation. The cell cycle kinetics of L1210 cells were studied by using a flow cytometer. The results showed that the transition of cells from G1 phase to S phase was blocked to certain extent by the treatment of GHM-10 4 micrograms.ml-1 for 12 h. The fluidity of cell membrane was also increased when the L1210 cells were exposed to 2-3 micrograms.ml-1 of GHM-10 for 24 h.
    [Abstract] [Full Text] [Related] [New Search]